Singular Genomics to be acquired by Deerfield for $20.00 per share in case

Merger Agreement Announcement: Singular Genomics Systems has entered into a definitive merger agreement with an affiliate of Deerfield Management Company, which will acquire the company for $20.00 per share, representing a 254% premium over its last closing price prior to the acquisition proposal.

Board Approval and Future Plans: The Singular Genomics Board of Directors approved the merger after a special committee's recommendation, and upon completion, the company will become private, allowing it greater flexibility in advancing its business strategy; the transaction is expected to close in the first half of 2025, pending stockholder approval.